Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr HIV Res. 2006 Jan;4(1):79-85.

Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.

Author information

  • 1Department of Medical Pathophysiology, University La Sapienza, Rome, Italy. g.barbaro@tin.it

Abstract

Highly active antiretroviral therapy (HAART) regimens, especially those including protease inhibitors have been shown to cause, in a high proportion of HIV-infected patients, a metabolic syndrome (lipodystrophy/lipoatrophy, dyslipidemia, type 2 diabetes mellitus, insulin resistance) that may be associated with an increased risk of cardiovascular disease. A careful stratification of the cardiovascular risk of HIV-infected patients under HAART is needed according to the most recent clinical guidelines.

PMID:
16454713
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Support Center